Skip to main content
logo
Noxopharm Limited (ASX:NOX)
Australia flag Australia · Delayed Price · Currency is AUD
0.0650
-0.0020 (-2.99%)
Sep 18, 2026, 1:54 PM AEST

Noxopharm Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
212716191357
Market Cap Growth
-20.86%69.38%-18.18%53.49%-77.95%-69.35%
Enterprise Value
25311214141
Last Close Price
0.070.090.050.070.040.20

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
14.4218.735.598.042.0910.50
PB Ratio
-5.64-7.3322.873.511.392.36
P/TBV Ratio
--22.873.511.392.36

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
17.4221.644.115.890.247.48

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
-1.25-1.253.59--0.01
Net Debt / Equity Ratio
-1.17-1.171.34-0.42-0.33-0.57
Net Debt / EBITDA Ratio
-1.25-1.25-0.170.500.291.46
Net Debt / FCF Ratio
-1.58-1.58-0.163.390.281.01
Asset Turnover
0.450.450.500.280.330.15
Inventory Turnover
-----10.67
Quick Ratio
0.330.331.163.799.458.43
Current Ratio
0.340.341.183.839.529.13
Return on Equity (ROE)
---157.93%-49.12%-90.72%-57.53%
Return on Assets (ROA)
-66.95%-66.95%-59.24%-34.01%-36.23%-16.42%
Return on Capital Employed (ROCE)
94.80%94.80%-757.40%-83.10%-116.10%-40.20%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-21.65%-16.67%-30.95%-18.55%-119.82%-32.76%
FCF Yield
-13.18%-10.15%-36.91%-3.55%-87.11%-24.10%
Buyback Yield / Dilution
-1.65%-1.65%---0.35%-10.37%